Doctors often monitor tumor markers in the blood to help diagnose and treat liver cancer. Alpha-fetoprotein (AFP) is the most common tumor marker that doctors monitor. Tumor markers, also called ...
March 27, 2008 — Within the Surveillance, Epidemiology, and End Results (SEER) registry, there is substantial variation in tumor-marker reporting for testis cancer, according to an analysis published ...
The use of tumor markers is an important component of diagnosis and management of testicular cancers, and failure to measure these markers might be deemed suboptimum care. In a recent paper, Gilbert ...
Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a ...
Tumor M2 Pyruvate Kinase: A Tumor Marker and its Clinical Application in Gastrointestinal Malignancy
Expert Rev Mol Diagn. 2008;8(5):579-585. Quite a few tumor markers (CEA, CA 19-9, AFP, SCC, CA 72-4.) have already been established in diagnosis and/or surveillance of malignant diseases of the GI ...
Role of Adjuvant Chemotherapy in Patients With Resected Non–Small-Cell Lung Cancer: Reappraisal With a Meta-Analysis of Randomized Controlled Trials The prognostic relevance of the rate of decline of ...
There are still no established biomarkers to predict the success of immunotherapy in patients with liver cancer. In a multicenter study led by Matthias Pinter from the Division of Gastroenterology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback